NYSEMKT: ARMP
Armata Pharmaceuticals Inc Stock Ownership - Who owns Armata Pharmaceuticals?

Insider buying vs selling

Have Armata Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Deborah BirxCEO2026-07-1014,041$4.26
$59.81kSell
Deborah BirxChief Executive Officer2026-03-144,919$10.54
$51.85kSell
Pierre KymeChief Business Officer2026-03-141,030$10.54
$10.86kSell

1 of 1

ARMP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ARMP insiders and whales buy or sell their stock.

ARMP Shareholders

What type of owners hold Armata Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Innoviva Inc67.44%25,076,769$146.45MInsider
Randal J. Kirk59.62%22,169,127$129.47MInsider
Biogen Inc37.49%13,939,158$81.40MInsider
Elan Corp PLC31.27%11,626,282$67.90MInsider
Austin W. Greenhouse David M. Marxe6.33%2,355,475$13.76MInsider
Delta Dental Of Wisconsin Inc5.67%2,107,675$12.31MInsider
Louis P. Lacasse3.90%1,450,185$8.47MInsider
Delta Dental Plan Of Michigan Inc3.40%1,265,802$7.39MInsider
Jeremy Curnock Cook1.11%411,435$2.40MInsider
Michael S. Perry1.11%411,335$2.40MInsider

1 of 3

ARMP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ARMP0.01%99.99%Net SellingNet Selling
VYGR0.06%48.15%Net Selling
PEPG0.08%9.73%Net Buying
PLX0.01%99.99%Net Buying
CHRS0.05%14.00%Net Selling

Armata Pharmaceuticals Stock Ownership FAQ

Who owns Armata Pharmaceuticals?

Armata Pharmaceuticals (NYSEMKT: ARMP) is owned by 0.01% institutional shareholders, 220.63% Armata Pharmaceuticals insiders, and 0.00% retail investors. Innoviva Inc is the largest individual Armata Pharmaceuticals shareholder, owning 25.08M shares representing 67.44% of the company. Innoviva Inc's Armata Pharmaceuticals shares are currently valued at $146.45M.

If you're new to stock investing, here's how to buy Armata Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.